CORTHERA
Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.
CORTHERA
Industry:
Biotechnology Health Care Therapeutics
Founded:
2002-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.corthera.com
Total Employee:
11+
Status:
Closed
Contact:
650-235-3555
Email Addresses:
[email protected]
Total Funding:
40.14 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Investors List
Domain Associates
Domain Associates investment in Series C - Corthera
Kleiner Perkins
Kleiner Perkins investment in Series C - Corthera
Caxton Advantage Life Sciences Fund
Caxton Advantage Life Sciences Fund investment in Series C - Corthera
Kleiner Perkins
Kleiner Perkins investment in Series B - Corthera
Domain Associates
Domain Associates investment in Series B - Corthera
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Corthera
Kleiner Perkins
Kleiner Perkins investment in Series A - Corthera
Domain Associates
Domain Associates investment in Series A - Corthera
